Home / News / World News / Article /
'Trial' drug associated with 70pc response rate in chronic lymphocytic leukaemia
Updated On: 12 December, 2011 10:58 AM IST | | ANI
A novel experimental agent for chronic lymphocytic leukemia (CLL) has been found to be highly active and well tolerated in patients who have relapsed and are resistant to other therapy, according to an interim study.
Listen to this article :
Read Next Story


